2010
DOI: 10.1007/978-3-642-10286-8_33
|View full text |Cite
|
Sign up to set email alerts
|

Renal Dysfunction in Chronic Liver Disease

Abstract: This article is one of ten reviews selected from the Yearbook of Intensive Care and Emergency Medicine 2010 (Springer Verlag) and co-published as a series in Critical Care. Other articles in the series can be found online at http://ccforum/series/yearbook. Further information about the Yearbook of Intensive Care and Emergency Medicine is available from http://www.springer.com/series/2855.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
35
0
6

Year Published

2011
2011
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 33 publications
(41 citation statements)
references
References 52 publications
(60 reference statements)
0
35
0
6
Order By: Relevance
“…As mentioned, HRS is potentially reversible following liver transplantation, so a renal transplant is inappropriate for most of these patients unless they have required renal replacement therapy for over 8 weeks. 1,16,20,23 Transjugular intrahepatic portosystemic shunt Non-pharmacological intervention such as a transjugular intrahepatic portosystemic shunt (TIPS) has its use in patients with portal hypertension, as in the treatment of variceal haemorrhage and refractory ascites, but its role in the treatment of renal failure in the context of liver disease is limited. In small studies, TIPS has been beneficial in some carefully selected patients, particularly as a bridge to liver transplantation or to delay the need to initiate dialysis or filtration.…”
Section: Dialysis and Continuous Renal Replacement Therapymentioning
confidence: 99%
“…As mentioned, HRS is potentially reversible following liver transplantation, so a renal transplant is inappropriate for most of these patients unless they have required renal replacement therapy for over 8 weeks. 1,16,20,23 Transjugular intrahepatic portosystemic shunt Non-pharmacological intervention such as a transjugular intrahepatic portosystemic shunt (TIPS) has its use in patients with portal hypertension, as in the treatment of variceal haemorrhage and refractory ascites, but its role in the treatment of renal failure in the context of liver disease is limited. In small studies, TIPS has been beneficial in some carefully selected patients, particularly as a bridge to liver transplantation or to delay the need to initiate dialysis or filtration.…”
Section: Dialysis and Continuous Renal Replacement Therapymentioning
confidence: 99%
“…Dieser Tatsache wird im MELD-Score zur Prädiktion der kurzfristigen Prognose bei Zirrhosepatienten durch die Berücksichtigung des Serumkreatinins zusammen mit dem Serumbilirubin und der INR Rechnung getragen. Nierenfunktionsstörungen bei Patienten mit Leberzirrhose ergeben sich aus 3 Hauptursachen: prärenales Nierenversagen, renales Nierenversagen im Sinne der akuten Tubulusnekrose und HRS [41,48].…”
Section: Niereninsuffizienzunclassified
“…Die Vasodilatation initiiert die Sekretion von Vasokonstriktoren (u. a. Renin-Angiotensin-Aldosteron-System, sympathisches Nervensystem, antidiuretisches Hormon), welche den renalen Blutfluss verringern [41,48]. Hierdurch steigt die Anfälligkeit für andere Risikofaktoren, wie die Verabreichung von nichtsteroidalen Antiphlogistika und intravenösem Kontrastmittel, oder für eine toxische Schädigung durch Gallensalze bzw.…”
Section: Niereninsuffizienzunclassified
See 2 more Smart Citations